Martha Sola-Visner

Martha Sola-Visner, MD, is an Associate Professor in Pediatrics at Harvard Medical School and a physician in the Division of Newborn Medicine at Boston Children's Hospital, where she serves as Director of the Newborn Medicine Clinical Research Program. Her clinical and research focus centers on neonatal hematology, platelet biology, and transfusion medicine, with extensive work on developmental differences in megakaryopoiesis and evidence-based transfusion guidelines.

Education:

• Medical School: Santiago de Guayaquil Catholic University (1992, Ecuador)
• Internship: University of Florida, Shands Teaching Hospital (1995)
• Residency (Pediatrics): University of Florida, Shands Teaching Hospital (1997)
• Fellowship (Neonatal-Perinatal Medicine): University of Florida, Shands Teaching Hospital (2000)

Research Focus: Dr. Sola-Visner investigates neonatal platelet physiology, transfusion outcomes, and developmental hematology. Her work spans sex-specific responses to transfusions, platelet function in sepsis, megakaryocyte biology, and implementation of restrictive transfusion protocols to improve neonatal outcomes. She utilizes proteomic, clinical trial, and translational approaches to address hematologic challenges in preterm infants.

Publication Trends: Her 15 most recent articles (2023-2025) emphasize platelet transfusion optimization, developmental differences in platelet signaling, transfusion-associated inflammatory pathways, and clinical guideline development. Recurring themes include sex-specific outcomes, proteomic profiling of neonatal platelets, and mechanistic links between transfusions and neonatal comorbidities like bronchopulmonary dysplasia.

Certifications: American Board of Pediatrics (Neonatal-Perinatal Medicine).